Back to Journals » Journal of Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma
ISSN: 2253-5969
- View all (595)
- Volume 11, 2024 (71)
- Volume 10, 2023 (176)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Journal Articles:
- 595 records -
A Comparison of Presentation, Treatment, and Survival After Hepatocellular Carcinoma of Viral and Non-Viral Etiology in Damietta, Egypt, 2007–2019
Jean K, Tawheed A, Luong Nguyen LB, Heikal T, Eldaly U, Elhadidy NG, Elghaieb A, Aboudonia A, Tondeur L, Dublineau A, Fontanet A, El-Kassas M
Journal of Hepatocellular Carcinoma 2024, 11:997-1004
Published Date: 31 May 2024
CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma
Palaz F, Ozsoz M, Zarrinpar A, Sahin I
Journal of Hepatocellular Carcinoma 2024, 11:975-995
Published Date: 30 May 2024
A Post-International Gastrointestinal Cancers’ Conference (IGICC) Position Statements
Yalcin S, Lacin S, Kaseb AO, Peynircioğlu B, Cantasdemir M, Çil BE, Hurmuz P, Doğrul AB, Bozkurt MF, Abali H, Akhan O, Şimşek H, Sahin B, Aykan FN, Yücel İ, Tellioğlu G, Selçukbiricik F, Philip PA
Journal of Hepatocellular Carcinoma 2024, 11:953-974
Published Date: 29 May 2024
Prediction of Microvascular Invasion and Recurrence After Curative Resection of LI-RADS Category 5 Hepatocellular Carcinoma on Gd-BOPTA Enhanced MRI
Zhang J, Li Y, Xia J, Pan X, Lu L, Fu J, Jia N
Journal of Hepatocellular Carcinoma 2024, 11:941-952
Published Date: 25 May 2024
Preoperative Antiviral Therapy and Long-Term Outcomes for Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Liver Resection: A Multicenter Analysis
Dai MG, Liu SY, Zhu L, Lu WF, Xie GL, Liang L, Liu JW, Ye B
Journal of Hepatocellular Carcinoma 2024, 11:927-939
Published Date: 23 May 2024
A Novel Nomogram to Predict Prognosis of Advanced Hepatocellular Carcinoma Treated with Intensity-Modulated Radiotherapy Plus Anti-PD1
He M, Liang C, Pang Y, Jiang M, Long M, Yao Z, Wang X, Zhang R, Wu Q, Liang S, Li J
Journal of Hepatocellular Carcinoma 2024, 11:913-925
Published Date: 22 May 2024
A Novel Nomogram to Predict Prognosis in Elderly Early-Stage Hepatocellular Carcinoma Patients After Ablation Therapy
Tang X, Wang Q, Jin R, Hu C
Journal of Hepatocellular Carcinoma 2024, 11:901-911
Published Date: 17 May 2024
Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing to Identify an Immunogenic Cell Death-Related 5-Gene Prognostic Signature in Hepatocellular Carcinoma
Peng L, Xu S, Xu JL
Journal of Hepatocellular Carcinoma 2024, 11:879-900
Published Date: 16 May 2024
Construction of a Prognostic Model for Hepatocellular Carcinoma Based on Macrophage Polarization-Related Genes
Chen H, Li J, Cao D, Tang H
Journal of Hepatocellular Carcinoma 2024, 11:857-878
Published Date: 11 May 2024
Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1)
Chava S, Ekmen N, Ferraris P, Aydin Y, Moroz K, Wu T, Thung SN, Dash S
Journal of Hepatocellular Carcinoma 2024, 11:839-855
Published Date: 9 May 2024
PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration
Gong Y, Zhou M, Zhu Y, Pan J, Zhou X, Jiang Y, Zeng H, Zheng H, Geng X, Huang D
Journal of Hepatocellular Carcinoma 2024, 11:813-838
Published Date: 8 May 2024
Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion
Yu Y, Wang XH, Hu WJ, Chen DH, Hu ZL, Li SQ
Journal of Hepatocellular Carcinoma 2024, 11:801-812
Published Date: 8 May 2024
CXCL9 Overexpression Predicts Better HCC Response to Anti-PD-1 Therapy and Promotes N1 Polarization of Neutrophils
Wang P, Xu MH, Xu WX, Dong ZY, Shen YH, Qin WZ
Journal of Hepatocellular Carcinoma 2024, 11:787-800
Published Date: 8 May 2024
A Modified Targetoid Feature Emphasizing Thin-Rim APHE to Improve the Diagnostic Performance of LI-RADS for Malignant Hepatic Tumors
Huang R, Zheng C, Xu G, Chen X, Shen J, Mao S
Journal of Hepatocellular Carcinoma 2024, 11:775-786
Published Date: 26 April 2024
Clinical Characteristics of Non-B and Non-C Biopsy-Proven Primary Liver Cancers in an HBV- Endemic Area: A Retrospective Study
Hu Z, Zhou H
Journal of Hepatocellular Carcinoma 2024, 11:767-774
Published Date: 24 April 2024
A Novel Four-Gene Signature Based on Nonsense-Mediated RNA Decay for Predicting Prognosis in Hepatocellular Carcinoma: Bioinformatics Analysis and Functional Validation
Zhao J, Wang C, Zhao L, Zhou H, Wu R, Zhang T, Ding J, Zhou J, Zheng H, Zhang L, Kong T, Zhou J, Hu Z
Journal of Hepatocellular Carcinoma 2024, 11:747-766
Published Date: 23 April 2024
Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis
Yang SH, He YS, Zheng SQ, Zhang XJ, Dai H, Xue Y
Journal of Hepatocellular Carcinoma 2024, 11:737-746
Published Date: 18 April 2024
Adjuvant Transarterial Chemoembolization Plus Immunotherapy for Huge Hepatocellular Carcinoma: A Propensity Score Matching Cohort Study
Huang H, Liao W, Zhang K, Wang H, Cheng Q, Mei B
Journal of Hepatocellular Carcinoma 2024, 11:721-735
Published Date: 8 April 2024
Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors
Gonvers S, Martins-Filho SN, Hirayama A, Calderaro J, Phillips R, Uldry E, Demartines N, Melloul E, Park YN, Paradis V, Thung SN, Alves V, Sempoux C, Labgaa I
Journal of Hepatocellular Carcinoma 2024, 11:707-719
Published Date: 6 April 2024
Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy
Xie D, Li Z, Yuan J, Yin X, Chen R, Zhang L, Ren Z
Journal of Hepatocellular Carcinoma 2024, 11:693-705
Published Date: 4 April 2024
Machine Learning Model Based on the Neutrophil-to-Eosinophil Ratio Predicts the Recurrence of Hepatocellular Carcinoma After Surgery
Shao G, Ma Y, Qu C, Gao R, Zhu C, Qu L, Liu K, Li N, Sun P, Cao J
Journal of Hepatocellular Carcinoma 2024, 11:679-691
Published Date: 3 April 2024
Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis
Wen Y, Lu L, Mei J, Ling Y, Guan R, Lin W, Wei W, Guo R
Journal of Hepatocellular Carcinoma 2024, 11:665-678
Published Date: 4 April 2024
High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization
Zhang B, Huang B, Yang F, Yang J, Kong M, Wang J, Xiang Y, Wang K, Peng R, Yang K, An C, Yan D
Journal of Hepatocellular Carcinoma 2024, 11:651-663
Published Date: 27 March 2024
The State of Systematic Therapies in Clinic for Hepatobiliary Cancers
Chen W, Hu Z, Li G, Zhang L, Li T
Journal of Hepatocellular Carcinoma 2024, 11:629-649
Published Date: 27 March 2024
The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients
Ma X, Sun X, Xie F, Jian W, Wang Q, Xie Y, Li C, Zhang K
Journal of Hepatocellular Carcinoma 2024, 11:619-628
Published Date: 25 March 2024
Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions
Long X, Zeng H, Zhang Y, Lu Q, Cao Z, Shu H
Journal of Hepatocellular Carcinoma 2024, 11:607-618
Published Date: 23 March 2024
Enhancement Pattern Mapping for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis
Nikzad N, Fuentes DT, Roach M, Chowdhury T, Cagley M, Badawy M, Elkhesen A, Hassan M, Elsayes KM, Beretta L, Koay EJ, Jalal PK
Journal of Hepatocellular Carcinoma 2024, 11:595-606
Published Date: 20 March 2024
Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
Chen P, Li Y, Dai Y, Wang Z, Zhou Y, Wang Y, Li G
Journal of Hepatocellular Carcinoma 2024, 11:581-594
Published Date: 19 March 2024
Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro
Du YQ, Yuan B, Ye YX, Zhou FL, Liu H, Huang JJ, Wei YF
Journal of Hepatocellular Carcinoma 2024, 11:565-580
Published Date: 19 March 2024
Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]
Yang H, Cong T, Luo Y, Yang C, Ren J, Li X
Journal of Hepatocellular Carcinoma 2024, 11:563-564
Published Date: 14 March 2024
LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma
Wei H, Wu X, Huang L, Long C, Lu Q, Huang Z, Huang Y, Li W, Pu J
Journal of Hepatocellular Carcinoma 2024, 11:543-562
Published Date: 11 March 2024
A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
Zong S, Huang G, Pan B, Zhao S, Ling C, Cheng B
Journal of Hepatocellular Carcinoma 2024, 11:525-542
Published Date: 12 March 2024
Machine Learning-Based Nomogram for Predicting Overall Survival in Elderly Patients with Cirrhotic Hepatocellular Carcinoma Undergoing Ablation Therapy
Qiao W, Sheng S, Li J, Jin R, Hu C
Journal of Hepatocellular Carcinoma 2024, 11:509-523
Published Date: 7 March 2024
Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative Liver Function-Nutrition-Inflammation-Immune (LFNII) Score: A Bicentric Investigation
Zhang BL, Liu J, Diao G, Chang J, Xue J, Huang Z, Zhao H, Yu L, Cai J
Journal of Hepatocellular Carcinoma 2024, 11:489-508
Published Date: 6 March 2024
Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma
Liu B, Gao S, Guo J, Kou F, Liu S, Zhang X, Feng A, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Xu L, Zhu X
Journal of Hepatocellular Carcinoma 2024, 11:477-488
Published Date: 4 March 2024
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy
Li W, Zheng Z, Wang J, Wu T, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z
Journal of Hepatocellular Carcinoma 2024, 11:463-475
Published Date: 4 March 2024
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma
Chamseddine S, LaPelusa M, Xiao L, Mohamed YI, Lee SS, Hu ZI, Hatia RI, Hassan M, Yao JC, Duda DG, Datar S, Amin HM, Kaseb AO
Journal of Hepatocellular Carcinoma 2024, 11:455-461
Published Date: 4 March 2024
Biochemical Safety of SBRT to Multiple Intrahepatic Lesions for Hepatocellular Carcinoma
Hall JT, Moon AM, Young M, Tan X, Darawsheh R, Danquah F, Tepper JE, Yanagihara TK
Journal of Hepatocellular Carcinoma 2024, 11:443-454
Published Date: 5 March 2024
Multiple Machine-Learning Fusion Model Based on Gd-EOB-DTPA-Enhanced MRI and Aminotransferase-to-Platelet Ratio and Gamma-Glutamyl Transferase-to-Platelet Ratio to Predict Microvascular Invasion in Solitary Hepatocellular Carcinoma: A Multicenter Study
Wang F, Yan CY, Qin Y, Wang ZM, Liu D, He Y, Yang M, Wen L, Zhang D
Journal of Hepatocellular Carcinoma 2024, 11:427-442
Published Date: 29 February 2024
Risks and Clinical Predictors of Hepatocellular Carcinoma in Chinese Populations: A Real-World Study of 10,359 Patients in Six Medical Centers
Huang C, Xiao X, Tong L, Gao Z, Ji J, Zhou L, Li Y, Liu L, Feng H, Fang M, Gao C
Journal of Hepatocellular Carcinoma 2024, 11:411-425
Published Date: 27 February 2024
Atezolizumab Plus Bevacizumab Combined with Transarterial Embolization Plus Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with a Diameter >8 Cm: A Retrospective Study
Cai H, Chen S, Wu Z, Wang F, Tang S, Chen L, Guo W
Journal of Hepatocellular Carcinoma 2024, 11:399-409
Published Date: 26 February 2024
A Deep Learning Model Combining Multimodal Factors to Predict the Overall Survival of Transarterial Chemoembolization
Sun Z, Li X, Liang H, Shi Z, Ren H
Journal of Hepatocellular Carcinoma 2024, 11:385-397
Published Date: 26 February 2024
Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1+ Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment
Liang Y, Zhong D, Yang Q, Tang Y, Qin Y, Su Y, Huang X, Shang J
Journal of Hepatocellular Carcinoma 2024, 11:373-383
Published Date: 22 February 2024
Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?
Himmelsbach V, Koch C, Trojan J, Finkelmeier F
Journal of Hepatocellular Carcinoma 2024, 11:363-372
Published Date: 19 February 2024
Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia
Alolyan A, Alshammari K, Arabi M, Alshehri A, Alsuhaibani H, Ibnshamsah F, Alsharm A, Mahrous M, Al Zanbagi A, Hassanain M, Bazarbashi S
Journal of Hepatocellular Carcinoma 2024, 11:349-362
Published Date: 16 February 2024
Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe [Response to Letter]
Liu J, Sun M, Fang K, Wang J, Ma B, Song L, Liu T, Tang M, Wang K, Xia Y
Journal of Hepatocellular Carcinoma 2024, 11:347-348
Published Date: 14 February 2024
Lipid Metabolism as a Potential Target of Liver Cancer
Wu K, Lin F
Journal of Hepatocellular Carcinoma 2024, 11:327-346
Published Date: 14 February 2024
The Index sAGP is Valuable for Distinguishing Atypical Hepatocellular Carcinoma from Atypical Benign Focal Hepatic Lesions
Luo QQ, Li QN, Cai D, Jiang S, Liu SS, Liu MS, Lv C, Wang JK, Zhang KH, Wang T
Journal of Hepatocellular Carcinoma 2024, 11:317-325
Published Date: 8 February 2024
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy
Shi Z, Zhu S, Jin Y, Qi L, Zhou M, Zhou Z, Zhang J, Liu B, Shen J
Journal of Hepatocellular Carcinoma 2024, 11:305-316
Published Date: 8 February 2024
RAD21: A Key Transcriptional Regulator in the Development of Residual Liver Cancer
Pang JS, Bai XM, Wan WJ, Kang T, Wen R, Li LP, Yin HH, Lu CM, Wen DY, He Y, Yang H
Journal of Hepatocellular Carcinoma 2024, 11:285-304
Published Date: 5 February 2024